United States

Halozyme to expand in San Francisco

Thursday, November 19, 2015

Halozyme Therapeutics, a biotechnology company developing novel oncology and drug-delivery therapies, will be expanding its facilities by opening a satellite office on Gateway Boulevard in South San Francisco. Halozyme is based in San Diego and currently has about 200 employees.

[Read More]

Viking Therapeutics submits IND application for VK2809

Wednesday, November 18, 2015

Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, has submitted an investigational new drug (IND) application to FDA to conduct a phase II study of VK2809 in patients with hypercholesterolemia and fatty liver disease.

[Read More]

Dyax named ‘Top Place to Work’

Wednesday, November 18, 2015

Dyax, a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs, has been named one of the Top Places to Work in Massachusetts by The Boston Globe for the second year in a row.

[Read More]

FDA approves new non-small cell lung cancer pill

Monday, November 16, 2015

The FDA has granted Accelerated Approval for an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC). Tagrisso (osimertinib) now is approved for patients whose tumors have a specific epidermal growth factor receptor (EGFR) mutation (T790M) and whose disease has gotten worse after treatment with other EGFR-blocking therapy.

[Read More]

Arxspan, Broad Institute partner on information management tools

Thursday, November 12, 2015

Arxspan, a cloud-based solutions provider based in Massachusetts, has entered into an agreement with the Broad Institute of MIT and Harvard for use of its ArxLab cloud-based suite of biological and chemical discovery information management tools. The partnership will support the institute’s efforts to electronically manage and share both biological and chemical research information internally and with external collaborators. The ArxLab suite of tools will be used for managing the institute’s electronic laboratory notebook, compound and assay registration, scientific analysis and search, biological visualization, and inventory management functions.

[Read More]